newsfilter
← Latest News
GlobeNewswire·

DICE Therapeutics to Host R&D Investor Event on Tuesday, June 20, 2023

SOUTH SAN FRANCISCO, Calif., June 13, 2023 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (NASDAQ:DICE) (DICE or the Company), a biopharmaceutical company leveraging its proprietary DELSCAPE technology platform to build a